Source: BIOSPECTRUM ASIA

AqueSys: Allergan completes AqueSys acquisition

Biospectrum AqueSys is a clinical-stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma [Read more]

Read full article »
AqueSys's Competitors | AqueSys's News | AqueSys's Financials
Stay up-to-date with the latest news on AqueSys
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Ron Bache's photo - President & CEO of AqueSys

President & CEO

Ron Bache

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on AqueSys